Arrowhead Pharmaceuticals, Inc.

OPPENHEIMER ASSET MANAGEMENT INC. ARWR

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/23/2026

Shares

7,740

Value ($000)

485

Weight

0.0%

2019 Q4 - 2026 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/23/2026	485	0.0%	7,740	3/31/2026
2022 Q4	2/7/2023	511	0.0%	12,592	12/31/2022
2022 Q3	11/14/2022	462	0.0%	13,964	9/30/2022
2022 Q2	8/8/2022	509	0.0%	14,449	6/30/2022
2022 Q1	5/12/2022	683	0.0%	14,845	3/31/2022
2021 Q4	2/2/2022	992	0.0%	14,960	12/31/2021
2021 Q3	11/12/2021	972	0.0%	15,563	9/30/2021
2021 Q2	8/3/2021	1,346	0.0%	16,256	6/30/2021
2021 Q1	5/17/2021	1,098	0.0%	16,564	3/31/2021
2020 Q4	2/11/2021	1,308	0.0%	17,048	12/31/2020
2020 Q3	11/13/2020	748	0.0%	17,362	9/30/2020
2020 Q2	8/11/2020	755	0.0%	17,471	6/30/2020
2020 Q1	5/8/2020	496	0.0%	17,256	3/31/2020
2019 Q4	2/7/2020	1,116	0.0%	17,599	12/31/2019